2.94MMarket Cap-13P/E (TTM)
3.0600High2.4100Low777.29KVolume2.4800Open2.4000Pre Close2.10MTurnover81.40%Turnover RatioLossP/E (Static)985.08KShares92.750052wk High3.32P/B2.85MFloat Cap2.190052wk Low--Dividend TTM954.92KShs Float6085800000.0000Historical High--Div YieldTTM27.08%Amplitude2.1900Historical Low2.6990Avg Price1Lot Size
Nuwellis Stock Forum
Nuwellis Announces First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical’s QUELIMMUNE™ Therapy at Cincinnati Children’s
Nuwellis, Inc. (Nasdaq: NUWE) announced the first commercial use of QUELIMMUNE™ therapy at Cincinnati Children's hospital. QUELIMMUNE, manufactured by SeaStar Medical (Nasdaq: ICU) and exclusively distributed by Nuwellis in U.S. pediatric hospitals, is designed to treat pediatric patients with acute kidney injury (AKI) and sepsis r...
short this to the center of earth. its a NO for children.
No comment yet